Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genmedix
Northampton, Northamptonshire, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Genmedix was a pharmaceutical company specializing in the development and supply of generic injectable oncology medicines. Based in the United Kingdom, the company focused on providing high-quality, cost-effective alternatives to branded cancer treatments. Its portfolio included essential chemotherapy agents such as paclitaxel, carboplatin, and cisplatin. The company operated with a focus on the European market, ensuring supply chain reliability for critical hospital-administered drugs. In 2011, Genmedix was acquired by Teva Pharmaceutical Industries, a move that significantly expanded Teva's oncology footprint in Europe. Following the acquisition, the company's operations and product lines were integrated into Teva's global generics business.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Pharma
Beyond the preview
Go deeper on Genmedix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genmedix.